4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-048750
Options or other derivatives
- CTO acquired 2,138,548 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| WACHTER ERIC PHD CTO | 2024-12-02 | Grant or award · Stock Options (Right to Buy) | +2,138,548 | 2,138,548 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…